Kala Bio Inc (KALA)
6.566
+0.24
(+3.73%)
USD |
NASDAQ |
Apr 23, 16:00
6.68
+0.11
(+1.73%)
After-Hours: 20:00
Kala Bio Price to Book Value: 2.464 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 2.464 |
| April 22, 2024 | 2.376 |
| April 19, 2024 | 2.473 |
| April 18, 2024 | 2.556 |
| April 17, 2024 | 2.567 |
| April 16, 2024 | 2.571 |
| April 15, 2024 | 2.627 |
| April 12, 2024 | 2.702 |
| April 11, 2024 | 2.702 |
| April 10, 2024 | 2.759 |
| April 09, 2024 | 2.781 |
| April 08, 2024 | 2.86 |
| April 05, 2024 | 2.852 |
| April 04, 2024 | 2.909 |
| April 03, 2024 | 2.920 |
| April 02, 2024 | 2.999 |
| April 01, 2024 | 2.999 |
| March 28, 2024 | 2.991 |
| March 27, 2024 | 2.887 |
| March 26, 2024 | 2.898 |
| March 25, 2024 | 2.909 |
| March 22, 2024 | 2.938 |
| March 21, 2024 | 2.942 |
| March 20, 2024 | 2.923 |
| March 19, 2024 | 2.839 |
| Date | Value |
|---|---|
| March 18, 2024 | 2.832 |
| March 15, 2024 | 2.769 |
| March 14, 2024 | 2.806 |
| March 13, 2024 | 2.813 |
| March 12, 2024 | 2.784 |
| March 11, 2024 | 2.876 |
| March 08, 2024 | 2.758 |
| March 07, 2024 | 2.695 |
| March 06, 2024 | 2.754 |
| March 05, 2024 | 2.749 |
| March 04, 2024 | 2.817 |
| March 01, 2024 | 2.695 |
| February 29, 2024 | 2.640 |
| February 28, 2024 | 2.642 |
| February 27, 2024 | 2.629 |
| February 26, 2024 | 2.66 |
| February 23, 2024 | 2.596 |
| February 22, 2024 | 2.942 |
| February 21, 2024 | 2.626 |
| February 20, 2024 | 2.637 |
| February 16, 2024 | 2.607 |
| February 15, 2024 | 2.640 |
| February 14, 2024 | 2.526 |
| February 13, 2024 | 2.570 |
| February 12, 2024 | 2.640 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.017
Minimum
Mar 01 2023
13.79
Maximum
Mar 24 2020
3.330
Average
2.942
Median
Feb 22 2024
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.273 |
| AIM ImmunoTech Inc | 2.224 |
| IGC Pharma Inc | 3.214 |
| NovaBay Pharmaceuticals Inc | 1.699 |
| Protalix BioTherapeutics Inc | 2.611 |
Price to Book Value Related Metrics
| PS Ratio | 2.777 |
| Price | 6.566 |
| Earnings Yield | -270.3% |
| Market Cap | 18.49M |